Rocket Pharmaceuticals Inc Earnings

The next earnings date for Rocket Pharmaceuticals Inc is May 11, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Rocket Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
05/11/2026	$-0.44

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Rocket Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
03/02/2026	---	$-0.38	11.23%
11/05/2025	---	$0	100.00%
08/11/2025	---	$-0.59	-4.86%
05/05/2025	Before Market	$-0.56	3.96%
02/24/2025	Before Market	$-0.62	13.64%
11/04/2024	Before Market	$-0.71	6.58%
08/05/2024	After Market	$-0.74	-2.78%
05/06/2024	After Market	$-0.66	2.94%
02/26/2024	After Market	$-0.64	18.99%
11/06/2023	After Market	$-0.75	7.41%
08/09/2023	After Market	$-0.82	-3.80%
05/04/2023	After Market	$-0.73	14.12%
02/27/2023	After Market	$-0.92	-15.00%
11/03/2022	After Market	$-0.87	-10.13%
08/08/2022	After Market	$-0.83	-22.06%
05/05/2022	After Market	$-0.67	5.63%
02/24/2022	Before Market	$-0.69	9.21%
11/03/2021	Before Market	$-0.79	-29.51%
08/09/2021	After Market	$-0.55	15.38%
05/10/2021	After Market	$-0.65	5.80%
02/25/2021	Before Market	$-1.08	-111.76%
11/04/2020	Before Market	$-0.53	-15.22%
08/05/2020	Before Market	$-0.45	11.76%
05/06/2020	Before Market	$-0.45	8.16%
03/05/2020	Before Market	$-0.39	20.41%
11/07/2019	Before Market	$-0.38	22.45%
08/07/2019	Before Market	$-0.38	22.45%
05/08/2019	Before Market	$-0.43	30.65%
03/07/2019	Before Market	$-0.66	-46.67%
11/07/2018	Before Market	$-0.40	6.98%
08/08/2018	Before Market	$-0.40	-11.11%
05/11/2018	Before Market	$-0.42	-27.27%
03/07/2018	Before Market	$-0.72	-132.26%
11/08/2017	Before Market	$-0.27	---
08/03/2017	After Market	$-0.96	48.94%
05/10/2017	Before Market	$-1.60	-1.91%
03/16/2017	Before Market	$-1.92	-10.98%
11/09/2016	Before Market	$-1.64	7.87%
08/10/2016	Before Market	$-1.32	16.46%
05/11/2016	Before Market	$-1.52	-72.73%
03/23/2016	Before Market	$-0.52	64.86%
11/12/2015	Before Market	$-1	45.65%
08/06/2015	After Market	$-0.12	87.76%
05/15/2015	Before Market	$-1.92	-21.52%
03/31/2015	Before Market	$-12.88	-631.82%

More About Rocket Pharmaceuticals Inc

Website

https://www.rocketpharma.com

Country

USA

Full Time Employees

202

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardiac disorder that is characterized by a progressive loss of cardiac muscle mass, severe right ventricular dilation, dysplasia, fibrofatty replacement of the myocardium and a high propensity to arrhythmias and sudden death (RP-A601), which is in phase 1; and BAG3 Dilated Cardiomyopathy (BAG3-DCM), which is a form of cardiomyopathy and is characterized by progressive thinning of the walls of the heart, which is in preclinical stage. It also develops ex vivo lentiviral (LV) programs, which include programs for Leukocyte Adhesion Deficiency-I (LAD-I), a genetic disorder that causes the immune system to malfunction (RP-L201); Fanconi Anemia (FA), a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells (RP-L102); and Pyruvate Kinase Deficiency (PKD), a red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia (RP-L301). It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red de Enfermedades Raras, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and Temple University. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.

“Rocket Pharmaceuticals Inc Earnings” Can Refer to the Rocket Pharmaceuticals Inc Earnings Date

Some people say “Rocket Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Rocket Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Rocket Pharmaceuticals Inc Stock on the Earnings Date

If you own Rocket Pharmaceuticals Inc stock (RCKT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Rocket Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Rocket Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Rocket Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Rocket Pharmaceuticals Inc earnings or anything else related to the stock market.